What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Food

Food Additives Nutraceutical

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1519302

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1519302

GABA Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED: July 15, 2024

PAGES: 250 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The GABA supplements market is poised for significant expansion, with projections indicating it will grow from $45.31 million in 2024 to $69.32 million by 2031, reflecting a CAGR of 6%. This growth highlights the increasing consumer awareness and demand for dietary supplements that aid relaxation, enhance sleep quality, and reduce anxiety. Capsules are expected to dominate the market in terms of revenue generation, showing substantial growth prospects in the coming years.

Key Factors Driving Market Growth

Several factors are driving the growth of the GABA supplements market. These supplements offer numerous health benefits, such as promoting brain relaxation, lowering stress levels, improving sleep quality, and reducing anxiety and hormonal irritability. In today's fast-paced environment, where stress, anxiety, and sleep disorders are common, these benefits are particularly valuable.

According to the Sleep Foundation, a significant number of adults globally suffer from insomnia, with chronic insomnia affecting a large portion of the population. Countries like Japan, the United States, the United Kingdom, and South Korea report high levels of sleep dissatisfaction, creating a significant opportunity for GABA supplements known for their relaxation and sleep-enhancing properties.

Impact of Covid-19 on Mental Health

The Covid-19 pandemic has significantly impacted mental health worldwide, leading to a marked increase in anxiety and depression. This surge has driven the demand for dietary supplements that promote relaxation and reduce anxiety. GABA supplements, known for supporting neurotransmitter function, are gaining popularity as effective solutions for these mental health concerns.

Addressing PMDD and Hypertension

Premenstrual dysphoric disorder (PMDD) affects many women, causing anxiety, depression, mood swings, and irritability. GABA supplements can help alleviate these symptoms, making them an attractive option for those seeking mental wellness and reduced inflammation.

Hypertension is another growing concern globally, with many adults affected. Studies indicate that GABA supplements can significantly lower blood pressure, offering a potential dietary solution for managing hypertension.

Supporting Underlying Medical Conditions

Individuals with conditions such as Parkinson's disease, hyperactivity disorder, and seizure disorders may have lower GABA levels. In these cases, GABA supplements can provide additional support by inducing calming effects and reducing anxiety.

Regional Market Insights

North America

North America is a leading market for GABA supplements, driven by high levels of chronic stress and anxiety and a significant portion of the population experiencing sleep-related issues.

United States

Anxiety disorders are among the most common mental health issues in the United States, affecting millions of adults annually. Many individuals prefer dietary supplements over traditional treatments to manage their anxiety, presenting a growth opportunity for GABA supplements.

United Kingdom

The United Kingdom has seen a rise in anxiety and depression, especially post-Covid-19. This has led to increased consumption of sleeping pills and anxiety medications, highlighting the need for non-harmful alternatives like GABA supplements.

Japan

Japan faces significant sleep disorder issues, with a large percentage of the population suffering from insomnia. This ongoing problem is driving the demand for GABA dietary supplements as a solution for better sleep and relaxation.

China

China's high prevalence of sleep disorders affects millions of people, influencing the demand for dietary supplements like GABA that promote better sleep and overall wellness.

South Korea

South Korea experiences notable stress and sleep-related issues, contributing to the demand for GABA supplements. The country's focus on skincare and wellness aligns with the benefits of GABA supplements, making them a popular choice for promoting beauty sleep and reducing stress.

Market Form and Competitive Analysis

GABA supplements come in various forms, including capsules, lozenges, powder, and gummies, with capsules projected to witness significant growth due to their convenience and efficacy.

Key players in the GABA supplements market include Now Foods, Horbaach, Pure Encapsulations, Thorne, Vitanica, Nutrabio, Country Life, Integrative Therapeutics, Solgar, and Nusa Pure. These companies offer a wide range of GABA supplements and provide resources such as stress-measuring tests and FAQs on their websites to assist consumers in selecting the best products for their needs.

Market Segmentation

By Form:

Capsules
Lozenges
Powder
Gummies

By Distribution Channel:

Online Stores
Pharmacies
Supermarkets
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global GABA Supplements Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global GABA Supplements Market Outlook, 2019-2031

3.1. Global GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Capsules
  - 3.1.1.2. Lozenges
  - 3.1.1.3. Powder
  - 3.1.1.4. Gummies
3.2. Global GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Online Stores
  - 3.2.1.2. Pharmacies
  - 3.2.1.3. Supermarkets
  - 3.2.1.4. Others
3.3. Global GABA Supplements Market Outlook, by Region, Value (US$ Mn), 2019-2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America GABA Supplements Market Outlook, 2019-2031

4.1. North America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Capsules
  - 4.1.1.2. Lozenges
  - 4.1.1.3. Powder
  - 4.1.1.4. Gummies
4.2. North America GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Online Stores
  - 4.2.1.2. Pharmacies
  - 4.2.1.3. Supermarkets
  - 4.2.1.4. Others
4.3. North America GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 4.3.1.2. U.S. GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 4.3.1.3. Canada GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 4.3.1.4. Canada GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

5. Europe GABA Supplements Market Outlook, 2019-2031

5.1. North America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Capsules
  - 5.1.1.2. Lozenges
  - 5.1.1.3. Powder
  - 5.1.1.4. Gummies
5.2. Europe GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Online Stores
  - 5.2.1.2. Pharmacies
  - 5.2.1.3. Supermarkets
  - 5.2.1.4. Others
5.3. Europe GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 5.3.1.2. Germany GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 5.3.1.3. U.K. GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 5.3.1.4. U.K. GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 5.3.1.5. France GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 5.3.1.6. France GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 5.3.1.7. Italy GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 5.3.1.8. Italy GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 5.3.1.9. Turkey GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 5.3.1.10. Turkey GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 5.3.1.11. Russia GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 5.3.1.12. Russia GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 5.3.1.13. Rest of Europe GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 5.3.1.14. Rest of Europe GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

6. Asia Pacific GABA Supplements Market Outlook, 2019-2031

6.1. Asia Pacific GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Capsules
  - 6.1.1.2. Lozenges
  - 6.1.1.3. Powder
  - 6.1.1.4. Gummies
6.2. Asia Pacific GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Online Stores
  - 6.2.1.2. Pharmacies
  - 6.2.1.3. Supermarkets
  - 6.2.1.4. Others
6.3. Asia Pacific GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 6.3.1.2. China GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 6.3.1.3. Japan GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 6.3.1.4. Japan GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 6.3.1.5. South Korea GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 6.3.1.6. South Korea GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 6.3.1.7. India GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 6.3.1.8. India GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 6.3.1.9. Southeast Asia GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 6.3.1.10. Southeast Asia GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 6.3.1.11. Rest of Asia Pacific GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 6.3.1.12. Rest of Asia Pacific GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

7. Latin America GABA Supplements Market Outlook, 2019-2031

7.1. Latin America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Capsules
  - 7.1.1.2. Lozenges
  - 7.1.1.3. Powder
  - 7.1.1.4. Gummies
7.2. Latin America GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Online Stores
  - 7.2.1.2. Pharmacies
  - 7.2.1.3. Supermarkets
  - 7.2.1.4. Others
7.3. Latin America GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 7.3.1.2. Brazil GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 7.3.1.3. Mexico GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 7.3.1.4. Mexico GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 7.3.1.5. Argentina GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 7.3.1.6. Argentina GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 7.3.1.7. Rest of Latin America GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 7.3.1.8. Rest of Latin America GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

8. Middle East & Africa GABA Supplements Market Outlook, 2019-2031

8.1. Middle East & Africa GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Capsules
  - 8.1.1.2. Lozenges
  - 8.1.1.3. Powder
  - 8.1.1.4. Gummies
8.2. Middle East & Africa GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Online Stores
  - 8.2.1.2. Pharmacies
  - 8.2.1.3. Supermarkets
  - 8.2.1.4. Others
8.3. Middle East & Africa GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 8.3.1.2. GCC GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 8.3.1.3. South Africa GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 8.3.1.4. South Africa GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 8.3.1.5. Egypt GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 8.3.1.6. Egypt GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 8.3.1.7. Nigeria GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 8.3.1.8. Nigeria GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
  - 8.3.1.9. Rest of Middle East & Africa GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
  - 8.3.1.10. Rest of Middle East & Africa GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

9. Competitive Landscape

9.1. Manufacturer vs by Distribution Channel Heatmap
9.2. Company Market Share Analysis, 2024
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Merz Inc
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Now Foods
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Horbaach
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Pure Encapsulations
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Thorne
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. VITANICA
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. NutraBio
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Country Life
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Integrative Therapeutics
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Solgar
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development
- 9.4.11. Nusa Pure
  - 9.4.11.1. Company Overview
  - 9.4.11.2. Product Portfolio
  - 9.4.11.3. Financial Overview
  - 9.4.11.4. Business Strategies and Development